HomeTagsBioCapital

BioCapital

Biotechnology

A2 Bio to Present at ASCO-GI 2022 to Identify GI Cancer Patients for Future Tmod™ CAR T Therapy

PR Newswire - January 19, 2022

A2 Biotherapeutics, Inc. ("A2 Bio") is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell therapy platform to...

spot_img

Hot Topics

RTX’s Collins Aerospace announces avionics modernization program for King Air and Hawker aircraft

Aptar and Nadara Collaborate to Drive Renewable Energy Generation in Europe

KalVista Appoints Jeb Ledell as Chief Operating Officer